Headaches in Pediatric Patients during the Past Decade: Comparative Analysis by Age Group from a Multicenter Study in

Eu Gene Park1,2, Seung Beom Han1, Jin Lee1,2

  • 1Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Brain Sciences
|October 25, 2024
PubMed

Insights

Pediatric headaches vary by age. Primary headaches are more common in adolescents, while secondary headaches are more frequent in preschoolers. Understanding these differences aids diagnosis.

Area of Science:

  • Pediatric Neurology
  • Clinical Epidemiology

Background:

  • Headache is a frequent complaint in children and adolescents.
  • Accurate diagnosis relies on understanding pediatric headache characteristics.
  • This study examined clinical features by etiology and age group.

Purpose of the Study:

  • To investigate clinical characteristics of pediatric headaches.
  • To analyze differences based on underlying etiology.
  • To compare headache features across different age groups.

Main Methods:

  • Retrospective review of 3374 pediatric patient records (2012-2023).
  • Categorization into primary headache (PH) and secondary headache (SH).
  • Analysis of data from two medical centers.

Main Results:

  • Primary headaches more prevalent in adolescents (40.1%) vs. preschoolers (22.9%).
  • Secondary headaches more prevalent in preschoolers (37.5%) vs. adolescents (16.3%).
  • Infections common cause in younger children; vascular/psychiatric disorders more frequent in adolescents.

Conclusions:

  • Etiology and age-specific differences are key for accurate pediatric headache diagnosis.
  • Tailoring diagnostic approaches improves patient outcomes.
  • Recognizing age-related patterns is crucial for timely and effective treatment.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...